- Home
- IMNM vs CBL Comparison
IMNM vs CBL Comparison
Compare IMNM & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- CBL
- Stock Information
- Founded
- IMNM 2006
- CBL 1978
- Country
- IMNM United States
- CBL United States
- Employees
- IMNM N/A
- CBL N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- CBL Real Estate Investment Trusts
- Sector
- IMNM Health Care
- CBL Real Estate
- Exchange
- IMNM Nasdaq
- CBL Nasdaq
- Market Cap
- IMNM 945.8M
- CBL 777.7M
- IPO Year
- IMNM 2020
- CBL 1993
- Fundamental
- Price
- IMNM $10.30
- CBL $31.70
- Analyst Decision
- IMNM Strong Buy
- CBL
- Analyst Count
- IMNM 7
- CBL 0
- Target Price
- IMNM $24.57
- CBL N/A
- AVG Volume (30 Days)
- IMNM 629.1K
- CBL 137.2K
- Earning Date
- IMNM 08-06-2025
- CBL 08-06-2025
- Dividend Yield
- IMNM N/A
- CBL 5.69%
- EPS Growth
- IMNM N/A
- CBL 128.05
- EPS
- IMNM N/A
- CBL 2.10
- Revenue
- IMNM $12,589,000.00
- CBL $539,452,000.00
- Revenue This Year
- IMNM N/A
- CBL N/A
- Revenue Next Year
- IMNM $154.73
- CBL N/A
- P/E Ratio
- IMNM N/A
- CBL $14.40
- Revenue Growth
- IMNM 16.74
- CBL 2.20
- 52 Week Low
- IMNM $5.15
- CBL $21.10
- 52 Week High
- IMNM $16.73
- CBL $33.54
- Technical
- Relative Strength Index (RSI)
- IMNM 53.80
- CBL 76.74
- Support Level
- IMNM $9.37
- CBL $30.13
- Resistance Level
- IMNM $10.39
- CBL $30.74
- Average True Range (ATR)
- IMNM 0.49
- CBL 0.64
- MACD
- IMNM -0.06
- CBL 0.18
- Stochastic Oscillator
- IMNM 52.81
- CBL 96.68
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.